Summary of Significant Accounting Policies (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Majority Owned Subsidiaries |
The accompanying condensed consolidated financial statements include the accounts of MariMed Inc. and the following majority-owned subsidiaries:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Assumptions Used |
The following table summarizes the range of inputs used by the Company during the nine months ended September 30, 2019 and 2018:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||